Exact Sciences (EXAS)

• Market cap: $8.48B
• 1 day: 1.90%
• 5 days: 2.42%
• 1 month: 5.43%
• 3 months: -18.54%
• 6 months: -35.23%
• Year to date: -19.83%
• 1 year: -23.10%
• 5 years: -42.21%
• 10 years: 118.37%
• Sector: Healthcare
• Industry: Diagnostics & Research

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

123% more call options, than puts

Call options by funds: $251M | Put options by funds: $112M

1% more first-time investments, than exits

New positions opened: 89 | Existing positions closed: 88

0.22% more ownership

Funds ownership: 98.49% [Q3] → 98.71% (+0.22%) [Q4]

1% less funds holding

Funds holding: 585 [Q3] → 578 (-7) [Q4]

11% less repeat investments, than reductions

Existing positions increased: 178 | Existing positions reduced: 200

17% less capital invested

Capital invested by funds: $12.4B [Q3] → $10.3B (-$2.11B) [Q4]

22% less funds holding in top 10

Funds holding in top 10: 9 [Q3] → 7 (-2) [Q4]

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $52 14% upside
• Avg. target: $62 36% upside
• High target: $73 60% upside

7 analyst ratings

• positive: 6 86%
• neutral: 1 14%
• negative: 0 0%

Guggenheim Subbu Nambi 33% 1-year accuracy 7 / 21 met price target	31% upside $60	Buy Reiterated	11 Apr 2025
Barclays Luke Sergott 36% 1-year accuracy 21 / 59 met price target	21% upside $55	Overweight Maintained	10 Apr 2025
Mizuho Anthony Petrone 45% 1-year accuracy 10 / 22 met price target	31% upside $60	Outperform Initiated	10 Apr 2025
RBC Capital Gerard Cassidy 38% 1-year accuracy 14 / 37 met price target	14% upside $52	Sector Perform Initiated	13 Mar 2025
Piper Sandler David Westenberg 45% 1-year accuracy 19 / 42 met price target	53% upside $70	Overweight Maintained	26 Feb 2025